ENKOJA中文ARTHVI
Delight Dermatology Clinic symbol logo
Gangnam, Seoul
Delight Dermatology

Hours & Location

Mon - Fri 10:00 - 20:00

Sat 10:00 - 16:00

Gangnam, Seoul

GLP-1 Recovery in Seoul — Post-GLP-1 deflation · layered restoration protocol

Post-GLP-1 deflation · layered restoration protocol

GLP-1 Recovery in Seoul

Layered restoration after rapid weight loss on Ozempic / Wegovy / Mounjaro / Zepbound. We do NOT prescribe GLP-1 medications — we restore the face and body after the GLP-1 effect. Core protocol: Sculptra (PLLA biostimulator, 3 sessions over 4-6 months — collagen scaffold), Radiesse (CaHA, including hyperdilute body off-label), and ONDA (Coolwaves 2.45 GHz — selective fat reduction + tightening). HA filler + Thermage FLX as adjuncts. Evidence anchor: Moradi 2026 multi-center experience. Honest timeline — 4-6 months minimum for visible Sculptra result.

Board-Certified

Dermatologist

AAD International Fellow

IFAAD

FDA-cleared

Where applicable

MFDS-registered

Korean MoH&W

Dr. SangYoul Yun
Reviewed personally by Dr. SangYoul Yun
Board-certified Dermatologist · AAD International Fellow (IFAAD) · IFAAD-verified
01

Overview

GLP-1 face and body recovery hub in Gangnam — Sculptra, Radiesse, and ONDA core layered protocol with HA and Thermage adjuncts, after Ozempic / Wegovy / Mounjaro weight loss.

Best for

  • Mid-face hollowing, temple deflation, infraorbital / submalar hollow ('Ozempic face')
  • Increased jowling, deepened nasolabial folds, marionette accentuation
  • Loss of facial luminosity and 'tired' surface quality
  • Neck laxity, jawline softening, submental fullness paradox
  • Upper-arm and abdominal skin laxity (body evidence weaker than face)
  • Décolletage crepiness post-rapid-weight-loss
  • Buttock / thigh skin laxity (hyperdilute body — skin-quality, NOT volumetric BBL)
  • Active GLP-1 therapy patients

Suited for

  • Adults 19+. Typical patient 35-65 with substantial body composition change in 6-18 months.
  • Patients currently on GLP-1 (we do NOT require discontinuation)
  • Patients who have plateaued (6-12 months in) — optimal for some components
  • Post-bariatric patients with parallel rapid-weight-loss pathology
  • Patients aware that GLP-1 weight loss includes ~25% lean mass component
  • Patients accepting 4-6 month timeline (Sculptra arc cannot be compressed)
  • Patients screened for biostimulator non-reversibility commitment
  • Multi-language consultation available; female staff on request.
Duration

Consultation 30-45 min

Sculptra single session 45-60 min

Thermage single session 45-60 min

HA filler 30-45 min

Hyperdilute body 60-90 min

Sessions

Sculptra 3 sessions × 4-6 weeks apart

Thermage single full-face session

HA filler 1-2 targeted syringes

Hyperdilute body 2-3 sessions × 4-6 weeks apart

Skin booster monthly during arc

Maintenance 12-18 months

Downtime

Bruising 3-7 days cannula / 5-7 days needle

Thermage no downtime

Strict daily mineral SPF 50+ across all modalities

48h vascular watch after HA filler and Radiesse before flying

Peak result

Month 6-12 combined Sculptra scaffold + mature collagen + Thermage remodeling + HA stable + skin booster surface luminosity

02

Timeline

  1. Day 0

    Sculptra: subtle plumping from saline carrier; full volumetric correction is NOT the Sculptra mechanism. HA: immediate correction. Thermage: mild collagen contraction. Mild swelling normal. Day 0 photos not representative.

  2. Day 1-7

    Bruising possible. HA settled by Week 1. Sculptra 'softening' Day 3 - Week 4 is expected (saline resorbs while PLLA begins biostimulator response).

  3. Month 1-3

    Sculptra 'softening trough' continues. Thermage RF remodeling building. Radiesse CMC gel resorbing, CaHA microspheres beginning fibroblast recruitment.

  4. Month 3-6

    Sculptra collagen response visible. Thermage at peak. Hyperdilute body skin-quality improvement (NOT volumetric). Skin booster luminosity visible.

  5. Month 6-12 (peak)

    Peak combined effect — Sculptra + Thermage + HA + booster mature. Restoration most visible. NOT 1-week or 1-month transformation.

  6. Month 12-24

    Sculptra durability past 24 months. HA 9-18 months. Thermage 12-18 months. Hyperdilute Radiesse 12-18 months on body. Annual maintenance review.

  7. Long-term

    Sculptra / Radiesse NOT reversible; HA is. Maintenance every 12-18 months. Inform radiologists of Radiesse history before X-ray / CT / mammography (microspheres detectable 24-30 months).

03

Devices

GLP-1 Recovery Core Stack — Sculptra · Radiesse · ONDA (+ HA Filler · Thermage FLX · Skin Booster adjuncts)

Sculptra (Galderma) · Radiesse (Merz Aesthetics) · ONDA (DEKA Italy) · HA fillers (Allergan / Galderma) · Thermage FLX (Solta Medical) · Rejuran (Pharma Research)All modalities FDA-approved / MFDS Class IV with site-specific indications. Hyperdilute Radiesse body is OFF-LABEL consensus, disclosed at consent. NONE is GLP-1-specific labeled — used per existing aesthetic indications framework.

Key specs

Sculptra (PLLA) — 3-session arc × 4-6 weeks, peak Month 6-12. Modern higher-dilution reduces nodule risk. HIV lipoatrophy clinical home translates to GLP-1 deflation.
Radiesse (CaHA) — face elasticity + hyperdilute body (1
1 to 1:6 saline) for skin-quality (NOT volumetric BBL). 2-3 sessions × 4-6 weeks. OFF-LABEL body disclosed.
ONDA Coolwaves 2.45 GHz — selective subcutaneous fat reduction + tightening for residual stubborn pockets. Combines with Sculptra + Radiesse.
HA filler (adjunct) — immediate volume in targeted compartments. Hyaluronidase-reversible.
Thermage FLX Total Tip 4.0 (adjunct) — monopolar RF for laxity layer. Single full-face session.
Skin booster (Rejuran / HA-based, adjunct) — monthly during Sculptra arc for surface luminosity.
Vascular safety
hyaluronidase on-site, 24/7 emergency contact for 72h, ophthalmology referral pathway within 60-90 min window.
NOT prescribed
GLP-1 medications (endocrinology / IM scope).
NOT offered
IV exosome / stem cell / IV GLP-1 booster / unapproved IV regenerative injection.
04

Process

  1. 01

    Consultation + 30-45 min 4-layer anatomical mapping (volume / scaffold / laxity / surface). GLP-1 history reviewed; we coordinate with prescribing physician. RESTORATION not weight-loss therapy — we do NOT prescribe GLP-1.

  2. 02

    Layered treatment plan: Sculptra foundation + targeted HA filler + Thermage FLX + hyperdilute Radiesse body + skin booster series. Tailored to deflation map, not full-menu default.

  3. 03

    Pre-treatment review — NSAIDs / fish oil / vitamin E / garlic paused 7-10 days. Anticoagulation NOT stopped without prescriber clearance. HSV: valacyclovir prophylaxis. Defer if active HSV.

  4. 04

    Sculptra Session 1 — 2 vials, 8-9 mL face dilution (16 mL body) per modern protocol. Cannula in vascular-risk zones; needle for deep boluses. '5-5-5 rule' aftercare. NOT in lips or under-eyes. 45-60 min.

  5. 05

    HA filler same-session OR 1-2 weeks later — targeted volume in deep nasolabial / marionette / chin / tear trough. Cannula default. Hyalase on-site for vascular rescue. REVERSIBLE — different class than Sculptra / Radiesse.

  6. 06

    Thermage FLX 4-8 weeks after Sculptra S1 (or parallel visit). Total Tip 4.0 × 900-1200 pulses × 45-60 min. Immediate contraction + 2-6 month remodeling.

  7. 07

    Sculptra Sessions 2-3 at Weeks 4-6 and 8-12 — redistributed per visible response. Full arc = 3 sessions over 8-12 weeks. NOT single-trip.

  8. 08

    Hyperdilute Radiesse body — 1:1 to 1:6 saline dilution. 22G blunt cannula subdermal fanning. SKIN-QUALITY not volumetric. 2-3 sessions × 4-6 weeks. OFF-LABEL disclosed.

  9. 09

    Skin booster series — Rejuran PN or HA-based monthly during Sculptra arc for surface luminosity.

  10. 10

    Long-term follow-up — peak Month 6-12, annual maintenance. Discharge packet for home dermatologist continuity.

“Injectables and energy devices are performed by physicians — never delegated to non-physician staff. The clinic is led by a board-certified dermatologist.”

— Dr. SangYoul Yun · Clinic Director · Board-Certified Dermatologist · AAD IFAAD
05

Aftercare

  1. Day 0 (24-72h vascular watch)

    Emollient + SPF 50+. Head elevated. Cold compress. Sculptra '5-5-5 rule' massage. NO massage after Thermage or Radiesse. Watch for blanching / dusky / mottled / severe disproportionate pain / vision change — 24/7 emergency line for 72h.

  2. Day 1-7

    Avoid alcohol / sauna / exercise / high-dose fish oil. Strict SPF 50+; sun avoidance to zones 14 days. Mild palpable firmness expected. Continue GLP-1 medication per prescribing physician.

  3. Weeks 2-4

    Resume normal skincare. Avoid dental cleaning 2 weeks / major dental work 4 weeks at injection zone (bacterial seeding risk). Booster series monthly during Sculptra arc.

  4. Weeks 2-12 (delayed inflammation watch)

    Watch for delayed nodules. Report new lump / tenderness / color change / systemic illness immediately. Early intervention gives better outcomes than late escalation.

  5. Long-term

    Peak combined effect at Month 6-12 — schedule review. Annual review thereafter. Touch-up typical 12-18 months. Inform radiologists of Radiesse history. Schedule restoration review if GLP-1 regimen changes.

06

FAQ

Should I stop GLP-1 before treatment?

Usually no. Moradi 2026 explicitly includes active-phase patients. Disclose full regimen at consultation — drug, dose, start date, current weight trajectory.

Can the full restoration be done in one Seoul trip?

No. Sculptra arc alone is 3 sessions × 4-6 weeks. One trip covers Sculptra S1 + Thermage + targeted HA over 5-7 days. Remainder: return trips or competent home-country PLLA injector. 6-12 week extended stay alternative.

Will facial volume return if I stop GLP-1?

Partially, only if you regain substantial weight, and unpredictably. Lean mass loss (~25% of total weight loss) is not restored automatically. Collagen scaffold change does NOT reverse with weight regain. Restoration addresses the structural change directly.

Sequence — Sculptra, Radiesse, HA, or Thermage first?

Layered: (1) Sculptra foundation first (longest maturation). (2) Targeted HA same-session or 1-2 weeks later. (3) Thermage 4-8 weeks after Sculptra S1. (4) Hyperdilute Radiesse for body in parallel. (5) Skin booster monthly during Sculptra arc.

Body skin laxity — arms, abdomen, buttocks?

Hyperdilute Radiesse + Thermage body. Body evidence is WEAKER than face (class-level consensus, not GLP-1-specific RCT). Patients seeking substantial body lift referred to plastic surgery for fat grafting evaluation.

Is hyperdilute Radiesse a non-surgical BBL?

No. Lorenc 2022 + Galadari 2024 are explicit — skin-quality / laxity protocol, NOT volumetric augmentation. For volumetric BBL we refer to plastic surgery.

Treat during active GLP-1 or wait for plateau?

Either is supported. Optimization: if actively losing, plan may need top-up sooner (further deflation). If plateaued ≥ 3-6 months, more aggressive first session OK. Pre-emptive treatment before deflation manifests not recommended.

Why Seoul vs my home city?

Multi-modality access in one consult + dense specialist competition + cannula-first technique + hyperdilute body protocol familiarity + single-physician planning. Honest caveat — Sculptra / Radiesse are globally available; if your home city has a competent dermatologist familiar with the framework, Seoul is not the only option.

Pricing? Insurance coverage?

Cosmetic — no insurance coverage even when underlying weight loss was medical. Per-session breakdown quoted in writing at consultation. Multi-session packages discount. Pre-trip virtual consult produces written quote.

Is GLP-1 a Korean-approved indication for restoration?

GLP-1 medications are MFDS-approved for diabetes / chronic weight management (endocrinology scope). Our restoration services are NOT GLP-1-specific indications — used per existing aesthetic indications. We do NOT prescribe GLP-1.

HA filler same day as Sculptra S1?

Yes, common pattern. Honest counsel: do NOT over-correct on HA expecting Sculptra to not deliver. Start conservative, see Sculptra response at S2 visit, adjust if more HA appropriate.

Realistic 6 / 12 / 24-month outcome?

Month 1-3: Sculptra 'softening trough' (expected, not failure). Month 3-6: Sculptra collagen builds. Month 6-12 peak combined. Month 12-24: durability past 24 months for Sculptra. Touch-up typical 12-18 months.

Most serious risk?

Vascular occlusion from HA / Radiesse (rare vision loss possible). Emergency protocol: immediate cessation, warm compress + nitroglycerin, hyaluronidase flooding, aspirin, ophthalmology referral within 60-90 min window. Sculptra-specific: nodule formation (modern higher-dilution reduces rates). 24/7 emergency contact for 72h.

IV exosome / NAD+ / stem cell / IV GLP-1 booster?

No. We keep this hub within MFDS regulatory framework. IV exosome / stem cell / IV GLP-1 booster all NOT offered. Basic skin care hub covers IV Drip (vitamin C / glutathione / Cindella) as separate decision.

Notice

Tell the dermatologist at consultation if any of the following apply.

  • Pregnancy or breastfeeding
  • Active skin infection or HSV at the site
  • Hypersensitivity to PLLA, CaHA, CMC, HA, hyaluronidase, or lidocaine
  • Active autoimmune flare, immunosuppression, or recent radiation — needs clearance
  • Implanted electronic device in the Thermage RF field
  • Therapeutic anticoagulation or recent dental work within 4 weeks — timing reviewed
  • Active rapid weight loss without plateau — timing reviewed at consultation

For your visit

  • Single-trip realistic scope — consultation + Sculptra S1 + Thermage + targeted HA over 5-7 days with 48h vascular watch. Full Sculptra arc does NOT fit one trip.
  • Multi-trip cadence: Trip 1 (foundation) + Trip 2 at Week 4-6 (Sculptra S2 + body S1) + Trip 3 at Week 8-12 (Sculptra S3 + body S2). Each 3-7 days. Annual maintenance Trip 4.
  • Extended-stay alternative: 6-12 week Seoul stay covers full arc + body protocols + bookend follow-up.
  • Active GLP-1 OK — no discontinuation required. We coordinate medication-day vs injection-day timing with prescribing physician.
  • Pre-trip virtual consultation available before flight booking. Written 3-track plan + quote schedule emailed.
  • Multi-language consultation available; clinic in Gangnam.
  • Discharge packet: Sculptra brand / lot / dilution / sessions, HA brand / lot / zone / volume, Thermage tip / pulses / energy, Radiesse dilution / sessions, photos + English clinical summary with Dr. Yun's stamp.
07

References

The clinical claims on this page — device specs, efficacy timelines, safety profile — are supported by the primary sources below. Each citation links to the original paper or regulatory record.14 refs
  1. [1]Emergence of 'ozempic face' — addressing unintended consequences of rapid weight loss (letter documenting hollowing through cheeks and temples, increased jowling, deeper nasolabial and marionette lines, skin laxity, loss of luminosity 6-12mo after starting therapy). Ann Med Surg (Jodat) (2026).
  2. [2]Losing Weight and Gaining Wrinkles — impact of weight loss drugs on facial aesthetics (review documenting skin laxity, body contouring, facial volume loss with GLP-1 agonists; restoration with dermal fillers, biostimulator agents, skin-tightening tech). J Craniofac Surg (Barişkan) (2026).
  3. [3]Nonsurgical Aesthetic Treatment of the Face and Neck in GLP-1 Receptor Agonist Weight Loss Patients — multi-center experience-based framework (CITATION ANCHOR for layered protocol; eligibility does not typically differ in this group; multimodal approach with HA fillers + collagen-stimulating energy-based devices + skin-quality treatments). Aesthet Surg J Open Forum (Moradi) (2026).
  4. [4]Effects of GLP-1 Receptor Agonists on Skin Homeostasis and Skin Aging Processes — review of dermal white adipose tissue reduction and decreased collagen synthesis with rapid weight loss; clinically resembles accelerated skin aging. J Clin Med (Žaliukaitė) (2026).
  5. [5]'Ozempic Face' — Treatment with Endotissutal Bipolar Radiofrequency — case series n=24, 12mo follow-up, transient cutaneous erythema only adverse event, high satisfaction (face-only RF data; body laxity evidence weaker). J Clin Med (Catalfamo) (2025).
  6. [6]Effect of GLP-1 RAs and Co-Agonists on Body Composition — network meta-analysis n=2258, 22 RCT, semaglutide and tirzepatide most effective for weight + fat reduction but among least effective in preserving lean mass; ~25% of total weight loss is lean mass. Metabolism (Karakasis) (2024).
  7. [7]Incretin-Based Weight Loss Pharmacotherapy — Can Resistance Exercise Optimize Body Composition? Review documenting ~10% / 6kg lean mass loss comparable to a decade of aging; resistance training adjunct strategy. Diabetes Care (Locatelli) (2024).
  8. [8]Randomized study of injectable poly-L-lactic acid versus human-based collagen — 25-month nasolabial fold correction durability in PLLA arm (CITATION ANCHOR for Sculptra durability claim in restoration context). J Am Acad Dermatol (Narins) (2010).
  9. [9]Poly-l-lactic acid for HIV-1 facial lipoatrophy — 48-week follow-up randomized trial (CITATION ANCHOR for Sculptra HIV-lipoatrophy clinical home translating to GLP-1 deflation pathology; same disproportionate adipose loss with intact skin envelope). HIV Med (Carey) (2009).
  10. [10]Soft-tissue augmentation and the role of poly-L-lactic acid — review of PLLA mechanism, gradual controlled neocollagenesis around hydrolyzing microparticles, semipermanent results with favorable safety profile. Plast Reconstr Surg (Vleggaar) (2006).
  11. [11]Global expert consensus on diluted and hyperdiluted CaHA for skin tightening — CITATION ANCHOR for hyperdilute Radiesse body protocol off-label use. Dermatol Surg (Goldie) (2018).
  12. [12]Hyperdilute CaHA practical consensus — Type I collagen response, NO lymphocytic infiltrate, skin-quality protocol NOT volumetric augmentation (CITATION ANCHOR for honest body laxity framing). Aesthet Surg J (Lorenc) (2022).
  13. [13]CaHA for face — systematic review of off-label scope and RCT evidence gap (CITATION ANCHOR for honest framing that body protocols have weaker evidence than face). Int J Dermatol (Galadari) (2024).
  14. [14]Korea highest filler vision loss cohort — Asian-skin filler complications meta-analysis (CITATION ANCHOR for vascular safety protocol urgency). Aesthet Plast Surg (Kapoor) (2019).
Reviewed byDr. SangYoul Yun· Board-Certified Dermatologist · AAD International Fellow (IFAAD) · ASLMS Member · Former Director, Banobagi Dermatology · KHIDI-registered International Patient Institution· Last reviewed 2026-05-16

Related procedures

Body Botox in Seoul | Trapezius, Calf, Biceps & Hyperhidrosis
ProcedureBody Botox in Seoul | Trapezius, Calf, Biceps & HyperhidrosisBody Botox in Seoul by a board-certified dermatologist — trapezius, calf, biceps, triceps, and axillary / palmar / plantar hyperhidrosis using Allergan Botox® or Merz Xeomin® only, with a 400-unit single-day cumulative cap.

Notice: Individual results may vary depending on skin condition, treatment history, and recovery factors. All treatment plans are determined through individual consultation with a board-certified dermatologist. The information on this page is for reference only and does not constitute medical advice or guarantee specific outcomes.

Next Step

You can start with a short message before deciding on GLP-1 Recovery.

Even a short first message can help you check suitability, timing, and what to compare next before you book.

Contact
WhatsAppLINEKakaoTalk
Gangnam, Seoul

Personalized dermatology care in Gangnam for local and overseas patients.

Delight Dermatology Clinic focuses on doctor-led consultation, warm service, and personalized treatment planning.

Walking videos

Nonhyeon · Exit 4
Sinnonhyeon · Exit 2
Navigate
Clinic

Delight Dermatology Clinic

4th Floor, Building B, 509 Gangnam-daero

Seocho-gu, Seoul, South Korea

Parking is available in the building.

02-517-9991

Mon - Fri: 10:00 - 20:00

Lunch break: 13:00 - 14:00

Saturday: 10:00 - 16:00

Sunday and public holidays: Closed

Location

Gangnam · Seocho-gu, Seoul

Find directions

Google MapsNaverKakao

Free Consult

WhatsApp

LINE

KakaoTalk

Google Maps

Phone

Instagram

Clinic Name: 딜라이트피부과의원Representative: 윤상열Tel. 02-517-9991Business Registration No.: 357-15-02460Privacy PolicyTerms of Use
Registered Foreign Patient Medical Institution
Officially registered by the Ministry of Health and Welfare of the Republic of Korea (Reg. No. M-2024-01-08-8248) · 외국인환자 유치의료기관

Medical information on this site is for reference only and does not constitute medical advice. Individual results may vary. Consult a board-certified dermatologist for diagnosis and treatment planning.

MapContact